ISLAMABAD and PRETORIA (9 November 2023)—The Association for Social Development (ASD) has registered 206 participants with drug-resistant tuberculosis (DR-TB) in
NEW YORK (September 15, 2023) — Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
NEW YORK (August 10, 2023)—Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license
“The addition of pretomanid to the Essential Medicines List (EML) of the World Health Organization (WHO) is a critical step
19 December 2022: Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the
PRETORIA (16 November, 2022)—A new study published in PLOS Global Public Health found that the BPaLM/BPaL treatment regimen that will
Imagining a TB-free world amidst resurgence during COVID-19 pandemic NEW YORK (March 24, 2022)—The world continues to battle against two
Agreement between non-profit product development partnership and multinational pharmaceutical company will expand access to new TB drug NEW YORK and
He will bring more than 20 years of global and country level experience in TB and a people-centered approach to
